Form 8-K - Current report:
SEC Accession No. 0000950170-22-026261
Filing Date
2022-12-09
Accepted
2022-12-09 08:30:26
Documents
14
Period of Report
2022-12-07
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tivc-20221207.htm   iXBRL 8-K 65827
2 EX-99.1 tivc-ex99_1.htm EX-99.1 16738
3 GRAPHIC img553027_0.jpg GRAPHIC 5192
  Complete submission text file 0000950170-22-026261.txt   215000

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tivc-20221207_lab.xml EX-101.LAB 13904
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tivc-20221207.xsd EX-101.SCH 2499
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tivc-20221207_pre.xml EX-101.PRE 10250
8 EXTRACTED XBRL INSTANCE DOCUMENT tivc-20221207_htm.xml XML 4893
Mailing Address 25821 INDUSTRIAL BLVD., SUITE 100 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BLVD., SUITE 100 HAYWARD CA 94545 (888)276-6888
Tivic Health Systems, Inc. (Filer) CIK: 0001787740 (see all company filings)

EIN.: 814016391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41052 | Film No.: 221453693
SIC: 3845 Electromedical & Electrotherapeutic Apparatus